|
|
Recent Articles
-
Best Idea Vertex Pharma Outperforming in 2022
Oct 10, 2022
-
Image Shown: Shares of Vertex Pharmaceuticals Inc, an idea included in our Best Ideas Newsletter portfolio, have performed incredibly well year-to-date through October 2022.
Vertex Pharma’s performance this year has been stellar, and its financial position is rock-solid. The company has ample financial firepower to invest heavily towards commercializing its existing drug development pipeline and is well-positioned to ride out the numerous exogenous shocks seen of late (inflationary pressures, geopolitical tensions, and the increasing likelihood of a global recession in the near term). We continue to like shares of VRTX in the simulated Best Ideas Newsletter portfolio.
-
Microsoft Hinted at Trouble in Calendar Q2 But AMD’s Massive $1 Billion Quarterly Q3 Revenue Miss Spells Big Problems for PC Market; Search and News Advertising Revenue Also Likely Weakening Substantially
Oct 8, 2022
-
Image Source: Fritzchens Fritz.
Economic conditions have deteriorated rapidly since Microsoft warned about deteriorating PC market demand in July of this year. AMD’s preliminary third-quarter report announced October 6 showed a massive $1 billion miss relative to prior expectations, and we think this is the beginning of a vicious cyclical downturn in the semiconductor industry, with few immune to the troubles, particularly in light of Apple’s warning about iPhone 14 demand. Further, we think search and news advertising has likely deteriorated since the calendar second-quarter reporting season, too, and this doesn’t bode well for the likes of Alphabet and Meta Platforms. Recent news about the strength of Tiktok and the lack of enthusiasm by Meta Platforms’ insiders that are building the metaverse have us thinking that Meta has turned into a value trap. We won’t hesitate to drop shares if the company’s outlook in its third-quarter report comes up short.
-
ICYMI: Things Have Changed Fast; Inflation and the Fed Have Damaged the Economy
Oct 7, 2022
-
Image Source: EpicTop10.com.
Things have changed fast. Inflation has turned from a positive catalyst in 2021 into a negative catalyst in 2022, all the while the 10-year Treasury rate has soared. We’ve yet to see the impact from a massive negative wealth effect from alternatives, to stocks/bonds, to the U.S. housing market, and the European financial system could eventually need life support as the U.K. bails out pension funds and the sharks start swarming around large European financial institutions. The writing is on the wall for tough times to come in 2023, and things will get worse before they get better. Buckle up because we’re going to be in for a wild ride in the coming 6-12 months, and maybe longer.
-
Dividend Increases/Decreases for the Week of October 7
Oct 7, 2022
-
Let's take a look at firms raising/lowering their dividends this week.
|
